Aggressive T-cell large granular lymphocyte leukemia: A case report and review of the literature

被引:38
作者
Alekshun, Todd J.
Tao, Jianguo
Sokol, Lubomir
机构
[1] Univ S Florida, Div Malignant Hematol, Dept Interdisciplinary Oncol, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Hematol & Oncol, Tampa, FL 33620 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Hematopathol & Lab Med, Tampa, FL 33620 USA
关键词
aggressive T-cell LGL leukemia; diagnosis; therapy; VARIANT; CD3(+);
D O I
10.1002/ajh.20853
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The majority of patients with T-cell large granular lymphocyte (LGL) leukemia will have an indolent clinical course. Herein, we report a case of an aggressive T-cell LGL leukemia in a previously healthy 42-year-old Caucasian male who presented with acute onset of B-symptoms, hepatosplenomegaly, lymphocytosis, moderate anemia, and thrombocytopenia. Immunophenotypically, the malignant cells co-expressed CD3(+)CD8(+)CD56(+) markers and the T-cell receptor beta (TCR beta) gene demonstrated clonal rearrangement. The patient was treated with an intensive chemotherapeutic regimen (hyper-CVAD) and he achieved a complete remission. A systematic review of all available English literature revealed 12 well-described cases of aggressive T-cell LGL leukemia suggesting that this variant is a new and distinct entity in the spectrum of LGL disorders.
引用
收藏
页码:481 / 485
页数:5
相关论文
共 10 条
[1]  
Chan J.K., 2001, PATHOLOGY GENETICS T, P198
[2]   Differential gene-expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T-cell large granular lymphocyte leukemia [J].
Daibata, M ;
Matsuo, Y ;
Machida, H ;
Taguchi, T ;
Ohtsuki, Y ;
Taguchi, H .
INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (06) :845-851
[3]  
Falcao RP, 2000, ACTA HAEMATOL-BASEL, V104, P110
[4]  
GENTILE TC, 1994, BLOOD, V84, P2315
[5]   Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia [J].
Kantarjian, HM ;
O'Brien, S ;
Smith, TL ;
Cortes, J ;
Giles, FJ ;
Beran, M ;
Pierce, S ;
Huh, Y ;
Andreeff, M ;
Koller, C ;
Ha, CS ;
Keating, MJ ;
Murphy, S ;
Freireich, EJ .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :547-561
[6]  
Kothapalli R, 2005, INT J ONCOL, V26, P529
[7]  
LOUGHRAN TP, 1993, BLOOD, V82, P1
[8]   Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes [J].
Macon, WR ;
Williams, ME ;
Greer, JP ;
Hammer, RD ;
Glick, AD ;
Collins, RD ;
Cousar, JB .
BLOOD, 1996, 87 (04) :1474-1483
[9]  
STEINHERZ PG, 1993, CANCER, V72, P3120
[10]  
Tordjman R, 1996, LEUKEMIA, V10, P1514